Quia Pharma AB
0
0
+SEK0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Quia Pharma AB (publ) engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform. The company develops drugs through its pegylation technology platform. Its product pipeline includes QPG-1030 (pegylated teduglutide) for the treatment of short bowel syndrome, and QPG-1029 under pre-clinical development for stable plasma concentration, as well as antibody-drug conjugates being developed using the company's Uni-Qleaver technology-platform. The company was formerly known as QuiaPEG Pharmaceuticals Holding AB (publ) and changed its name to Quia Pharma AB (publ). Quia Pharma AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
Show More
CEO
Dr. Vidar Wendel-Hansen M.D., Ph.D.
Employees
2
Country
Sweden
ISIN
SE0023849716
Listings
0 Comments
Share your thoughts
FAQs
What is Quia Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Quia Pharma AB stocks are traded under the ticker QUIA-BT-UN.ST.
How many employees does Quia Pharma AB have?▼
As of October 8, 2026, the company has 2 employees.
In which sector is Quia Pharma AB located?▼
Quia Pharma AB operates in the Health & Wellness sector.
When did Quia Pharma AB complete a stock split?▼
Quia Pharma AB has not had any recent stock splits.
Where is Quia Pharma AB headquartered?▼
Quia Pharma AB is headquartered in Uppsala, Sweden.